Navigation Links
Regulus to Present at Future Leaders in the Biotech Industry Conference
Date:3/28/2013

LA JOLLA, Calif., March 28, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Garry E. Menzel , Ph.D., Chief Operating Officer and Executive Vice President, Finance, will present a company overview at the 20th Annual Future Leaders in the Biotech Industry Conference on Friday, April 5, 2013 at 10:30 am EDT.  The conference is being held at the Millennium Broadway Hotel and Conference Center in New York City.

The presentation will be webcast at the time of the presentation and can be accessed on the Investor Relations page of the Company's website at www.regulusrx.com.  A replay of each webcast will be archived on the Company's website following the presentation date.

About Regulus

Regulus Therapeutics Inc. (NASDAQ: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is leveraging a mature therapeutic platform based on technology that has been developed over 20 years. Regulus works with a broad network of academic collaborators and leverages the oligonucleotide drug discovery and development expertise of its founding companies, Alnylam Pharmaceuticals and Isis Pharmaceuticals. Regulus is advancing microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis, hepatitis C and metabolic diseases. Regulus has formed strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi and a research collaboration with Biogen Idec.

For more information, please visit ht
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regulus to Present at Cowen and Company 33rd Annual Healthcare Conference
2. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
3. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
4. Regulus to Present at Two Upcoming Investor Conferences
5. Regulus Appoints Mark G. Foletta to its Board of Directors
6. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
7. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
8. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
9. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
10. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
11. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Calif. , Sept. 16, 2014  ROX ... trial, an international multi-center, prospective, randomized, controlled, blinded ... treatment of arterial hypertension. The CONTROL-HTN trial, NCT01642498, evaluated ... creating a fixed connection between a central artery ... the treatment of hypertension. The primary outcomes are ...
(Date:9/16/2014)... 2014 The Pulmonary Fibrosis Foundation (PFF) announced ... than 1,100 patients and families suffering from pulmonary fibrosis ... for the Patient-Focused Drug Development Meeting for Idiopathic Pulmonary ... initiative to seek patient input in order to better ... "We applaud the FDA for focusing its attention ...
(Date:9/16/2014)... 16, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... on licensing, developing and commercializing innovative biopharmaceutical products ... commencing an underwritten registered public offering of shares ... are being offered by Aratana Therapeutics. ... joint book-running managers for the offering.  ...
Breaking Medicine Technology:ROX Medical presents positive data for CONTROL-HTN resistant hypertension trial 2PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 2PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 3PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 4Aratana Therapeutics, Inc. Announces Proposed Public Offering 2
... WASHINGTON, March 3, 2011 The Generic Pharmaceutical ... drug manufacturers and suppliers, has honored Pharmaceutical ... Merritt with the industry,s prestigious "Outstanding Contribution" ... ) The award was presented at ...
... We are pleased to announce the launch of ... database of contract laboratory outsourcing and regulatory opportunities. ... vendors to fulfill your contract laboratory testing and ... regulatory outsourcing assignments. You also can post free for a ...
Cached Medicine Technology:Generic Drug Industry Honors PCMA President & CEO Mark Merritt with Prestigious 'Outstanding Contribution' Award 2Announcing New Contract Laboratory Testing and Outsourcing Web Database 2
(Date:9/17/2014)... 2014 In honor of National Health ... to health IT professionals for gaining a competitive edge ... by HIMSS shows demand for qualified health IT professionals ... set is the differentiating factor when filling a position. ... professional that has clinical workflow and terminology experience. American ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Lee Berman, ... industry, will be appearing on The Balancing Act® airing ... September episodes. , The segment will premiere on September ... 'The Balancing Act® airing on Lifetime Television®' with show ... Asset Funding Corp. for over a decade and is ...
(Date:9/17/2014)... On October 1-2, Voom will be adding ... Techmanity, a celebration of the intersection of life and ... Techmanity will host the best and brightest across the ... of Cisco, PayPal, Samsung, Silicon Valley Bank, and Adobe ... , Voom was created to address the health concerns ...
(Date:9/17/2014)... Health.Verticalize, a healthcare marketing company which helped ... options in the 2014 open enrollment period, has announced ... Health Network will be using HealthNetwork.com ... remained out of the spotlight for the last twelve ... to its present position with dozens of targeted sites ...
(Date:9/17/2014)... Presence Technology, a multinational provider ... Suite 10.0, which incorporates significant enhancements to meet ... , The Contact Center Agents and Supervisors will ... get a better feel for the performance of ... and who requires additional coaching or mentoring to ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Lee Berman Will Appear On The Balancing Act® airing on Lifetime Television® 2Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 3Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2
... moxifloxacin cut recovery time by 2 months, researchers say ... antibiotic moxifloxacin to the standard combination of drugs used ... the time needed to cure patients from six months ... study of more than 170 people in Rio de ...
... George Abercrombie, president,and chief executive officer, Hoffmann-La Roche ... at The Economic Club of Memphis that the,threat ... unlike those,anticipated with traditional emergency preparedness plans. ... for potential,disasters such as floods or tornadoes," according ...
... -- A single dose of Otsukas investigational oral ... favorable changes in hemodynamics associated with a significant ... heart failure (ADHF) who participated in the international ... in Subjects with HEart failure (ECLIPSE), presented at ...
... A Florida pharmacy,owner and a Kentucky physician pleaded ... pharmacy business that generated more than,$126 million in ... Assistant Attorney General Alice S. Fisher of the ... the Southern District of,California announced today. Claude ...
... 2008, RANCHO MIRAGE, Calif., Sept. 19 The,International ... first,annual Gala, "The South American Extravaganza" February 8, 2008. ... The elegant black-tie dinner will be held at the ... at 6:00 pm with cocktails. At,7:00 pm, a dinner ...
... Calif., Sept. 19 Over 800 patients ... survey conducted by the Renal,Support Network, a ... that affect the care of patients with ... education, reimbursement for,transplant medications and dialysis services. ...
Cached Medicine News:Health News:Newer Antibiotic Speeds TB Healing 2Health News:CEO Addresses Tennessee Business Leaders About Developing Pandemic and Business Continuity Plans 2Health News:CEO Addresses Tennessee Business Leaders About Developing Pandemic and Business Continuity Plans 3Health News:ECLIPSE data on effects of Otsuka's investigational novel treatment, Tolvaptan 2Health News:Doctor and Pharmacy Owner Plead Guilty in Internet Pharmacy Conspiracy 2Health News:Doctor and Pharmacy Owner Plead Guilty in Internet Pharmacy Conspiracy 3Health News:IMA South American Extravaganza Dinner to Honor Coachella Valley Doctor 2Health News:New Survey Reveals Kidney Patients' Concern About Medicare Policies 2
1.0 mm long 120 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 130 degrees....
Angled for easy insertion into side port incision for manipulation of nucleus. Flat, paddle like tip for placement in groove to crack the nucleus for emulsification....
Straight shaft with 0.2 mm hour glass shape tip. Round knurled handle with dull finish. Manufactured in titanium....
Medicine Products: